慢性閉塞性肺疾患(COPD)治療薬の世界市場2016-2020...市場調査レポートについてご紹介

【英文タイトル】Global Chronic Obstructive Pulmonary Disease Drugs Market 2016-2020

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

PART 01: Executive summary
• Highlights

PART 02: Scope of the report
• Market overview
• Top-vendor offerings

PART 03: Market research methodology
• Research methodology
• Economic indicators

PART 04: Introduction
• Key market highlights
• Breakthrough in COPD research
• COPD: An overview

PART 05: Pipeline analysis

PART 06: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis

PART 07: Key buying criteria for COPD drugs

PART 08: Market segmentation by drug class
• Combination therapies
• Bronchodilators
• Steroids
• Leukotriene antagonists
• PDE-4 inhibitors
• Other medications

PART 09: Segmentation by ROA
• Inhalation
• Oral

PART 10: Drug delivery devices market for COPD drugs
• Market overview
• Market segmentation by product type

PART 11: Geographical segmentation
• Global COPD drugs market by geography 2015-2020
• COPD drugs market in Americas
• COPD drugs market in EMEA
• COPD drugs market in APAC
• COPD drugs market in China

PART 12: Market drivers
• Increase in smoking prevalence
• Uptake of LABA/LAMA combination therapies
• Robust pipeline with tentative approval of drugs

PART 13: Impact of drivers

PART 14: Market challenges
• Lack of innovation in pipeline molecules
• Negligence toward use of controller medications
• Low diagnosis rates

PART 15: Impact of drivers and challenges

PART 16: Market trends
• Innovative technologies for drug delivery
• Increased adoption of e-cigarettes and smoking cessation products
• Emergence of ultrasonic nebulizers
• Increase in online marketing services
• Growing use of home healthcare devices

PART 17: Vendor landscape
• Competitive scenario
• Key news

PART 18: Key vendor analysis
• AstraZeneca
• Boehringer Ingelheim
• GSK
• Novartis
• Teva Pharmaceuticals
• Other prominent vendors

PART 19: Appendix
• List of abbreviations

PART 20: Explore Technavio

[List of Exhibits]

Exhibit 01: Product offerings
Exhibit 02: Breakthrough research activities in field of COPD
Exhibit 03: Percentage share of pipeline molecules based on stage of development
Exhibit 04: Pipeline molecules based on MOA and stage of development
Exhibit 05: Percentage share of pipeline drugs based on MOA
Exhibit 06: Global COPD drugs market 2015-2020 ($ billions)
Exhibit 07: Global COPD drugs market snapshot: Developed and emerging markets 2015
Exhibit 08: Global COPD drugs market: Key parameters driving the market 2015
Exhibit 09: Five forces analysis
Exhibit 10: Key buying criteria for COPD drugs
Exhibit 11: Impact of key customer segments on global COPD drugs market
Exhibit 12: Segmentation of COPD drugs based on drug class
Exhibit 13: Percentage share of global COPD drugs by drug class based on revenue 2015
Exhibit 14: Global COPD drugs market: Drug class segmentation growth cycle analysis 2015
Exhibit 15: Combination therapies market in global COPD drugs market 2015-2020 ($ billions)
Exhibit 16: Bronchodilators market in global COPD drugs market 2015-2020 ($ billions)
Exhibit 17: Steroid drugs market in global COPD drugs market 2015-2020 ($ billions)
Exhibit 18: Leukotriene antagonists market in global COPD drugs market 2015-2020 ($ billions)
Exhibit 19: YoY growth and revenue of Daliresp 2012-2015 ($ billions)
Exhibit 20: Global COPD drugs market segmentation by drug class 2015
Exhibit 21: Segmentation of global COPD drugs market by ROA
Exhibit 22: Global COPD drug delivery devices market 2015-2020 ($ millions)
Exhibit 23: Global COPD devices market segmentation by product type
Exhibit 24: Percentage share of global COPD drug delivery devices by type 2015
Exhibit 25: Percentage share of inhalers in global COPD drug delivery devices market 2015
Exhibit 26: Inhalers market in global COPD drug-devices market 2015-2020 ($ millions)
Exhibit 27: Percentage share of nebulizers in global COPD drug delivery devices market by technology 2015
Exhibit 28: Nebulizers market in global COPD drug-devices market 2015-2020 ($ millions)
Exhibit 29: Global COPD drugs market by geography 2015-2020
Exhibit 30: Percentage share of global COPD drugs market by geography 2015 and 2020
Exhibit 31: Global COPD drugs market segmentation by geography 2015-2020 ($ billions)
Exhibit 32: Global share of COPD drugs market by geography 2015
Exhibit 33: COPD drugs market in Americas 2015-2020 ($ billions)
Exhibit 34: Prevalence rates of COPD in few countries of EMEA
Exhibit 35: COPD drugs market in EMEA 2015-2020 ($ billions)
Exhibit 36: COPD drugs market in APAC 2015-2020 ($ billions)
Exhibit 37: COPD drugs market in China 2015-2020 ($ billions)
Exhibit 38: Global COPD drugs market: Country analysis based on revenue and growth rate
Exhibit 39: Drug approvals in COPD drugs market in past three years (2014-2016)
Exhibit 40: Few COPD drug molecules in registration stage
Exhibit 41: Impact of drivers
Exhibit 42: Controller and rescue medications for the treatment of COPD
Exhibit 43: Impact of drivers and challenges
Exhibit 44: Key vendors ranking 2015
Exhibit 45: Market share of key vendors based on revenues 2015
Exhibit 46: Geographical presence of key vendors
Exhibit 47: Competitive scenario of global COPD drugs market vendors 2015-2020
Exhibit 48: AstraZeneca: YoY revenue and growth rate of Symbicort 2013-2015 ($ billions)
Exhibit 49: AstraZeneca: Geographical segmentation of Symbicort 2015
Exhibit 50: AstraZeneca: YoY revenue and growth rate of Pulmicort 2013-2015 ($ millions)
Exhibit 51: AstraZeneca: Geographical segmentation of Pulmicort 2015
Exhibit 52: AstraZeneca: Metrics analysis
Exhibit 53: Boehringer Ingelheim: YoY revenue and growth rate of Spiriva 2013-2015 ($ billions)
Exhibit 54: Boehringer Ingelheim: Metrics analysis
Exhibit 55: GSK: YoY revenue and growth rate of Seretide/Advair 2013-2015 ($ billions)
Exhibit 56: Geographical segmentation of Seretide/Advair 2015
Exhibit 57: GSK: YoY revenue and growth rate of Flixotide/Flovent 2013-2015 ($ billions)
Exhibit 58: GSK: Geographical segmentation of Flixotide/Flovent 2015
Exhibit 59: GSK: YoY revenue and growth rate of Ventolin 2013-2015 ($ billions)
Exhibit 60: GSK: Geographical segmentation of Ventolin 2015
Exhibit 61: GSK: YoY growth and revenue of Relvar/Breo Ellipta 2014-2015 ($ millions)
Exhibit 62: GSK: Geographical segmentation of Relvar/Breo Ellipta 2015
Exhibit 63: GSK: YoY growth and revenue of Anoro Ellipta 2014-2015 ($ millions)
Exhibit 64: GSK: Geographical segmentation of Anoro Ellipta 2015
Exhibit 65: GSK: Metrics analysis
Exhibit 66: Novartis: YoY revenue and growth rate of Onbrez Breezhaler/Arcapta Neohaler 2014-2015 ($ millions)
Exhibit 67: Novartis: YoY revenue and growth rate of Seebri Breezhaler 2013-2015 ($ millions)
Exhibit 68: Novartis: YoY revenue and growth rate of Ultibro Breezhaler 2013-2015 ($ millions)
Exhibit 69: Novartis: Metrics analysis
Exhibit 70: Teva Pharmaceuticals: YoY revenue and growth rate of ProAir 2013-2015 ($ millions)
Exhibit 71: Teva Pharmaceuticals: YoY revenue and growth rate of Qvar 2013-2015 ($ millions)
Exhibit 72: Teva Pharmaceuticals: Metrics analysis


【レポート販売概要】

■ タイトル:慢性閉塞性肺疾患(COPD)治療薬の世界市場2016-2020
■ 英文:Global Chronic Obstructive Pulmonary Disease Drugs Market 2016-2020
■ 発行日:2016年7月20日
■ 調査会社:Technavio
■ 商品コード:IRTNTR9968
■ 調査対象地域:グローバル
  • AGL Energy Limited社の石油・ガス開発・生産動向及びコスト分析(2013年)
    AGL Energy Limited Oil & Gas Exploration and Production Operations and Cost Analysis - 2013 Summary AGL Energy Limited Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key o …
  • Exco Resources, Inc.:石油・ガスバリューチェーン分析レポート2013
    Exco Resources, Inc. Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Exco Resources, Inc." Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Exco Resources, Inc.”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report exam …
  • 事務用家具の世界市場2016-2020
    About the Office Furniture Market Multinational companies are expanding their businesses worldwide into new cities and countries and the corporate sector is realizing ever-increasing profits. In a bid to make these office spaces more employee-friendly and comfortable to work in, employers are using innovative furniture and design concepts. The rising number of employees also necessitates higher in …
  • DC-DCコンバータの世界市場予測(~2021年)
    The DC-DC converters market is expected to grow from USD 3.46 Billion in 2016 to USD 3.94 Billion by 2021, at a CAGR of 2.66%. Factors, such as growing concern towards global energy consumption, introduction of advanced power saving architectures, increasing demand in current requirements by the ICT industry, and the emergence of digital power management and control technologies are expected to dr …
  • 喘息&COPDの世界市場2016-2026
    Visiongain’s comprehensive new 313 page report reveals that the global asthma & COPD market will achieve revenues of $33.2bn in 2016. Are you involved in the asthma & COPD market or intend to be? If so, then you must read this report. It’s vital that you keep your knowledge up to date. You need this report. Market scope: Asthma & COPD are among the most common and debilitating respiratory conditio …
  • バイオ接着剤の世界市場2016-2020
    About Bioadhesives Bioadhesives are natural polymers that are used as adhesives. These are synthetically produced using organic monomers such as sugars. Bioadhesives materials build a resilient interface between two categories of materials such as soft and hard materials, which display certain characteristics that make them different from synthetic adhesives. Proteins and carbohydrates are the pri …
  • メキシコの病院用品市場(~2021)
    Mexico Hospital Supplies Market Outlook to 2021 - Disposable Hospital Supplies, Mobility Aids and Transportation Equipment, Operating Room Equipment, Patient Examination Devices, Sterilization Equipment and Syringes and Needles Summary GlobalData’s new report, "Mexico Hospital Supplies Market Outlook to 2021 - Disposable Hospital Supplies, Mobility Aids and Transportation Equipment, Operating Room …
  • 世界のM2Mネットワークセキュリティ製品市場(2014-2018)
    About M2M Network Security M2M communications enable data sharing between two or more machines in real time. A sensor attached to the machine captures the event and relays through a secure network, which can be wireless or wired. It then collects at the other side to initiate the necessary action. M2M communications have numerous advantages for organizations as it reduces human intervention and en …
  • 重要インフラストラクチャ保護(CIP)の世界市場予測(~2021)
    MarketsandMarkets forecasts the critical infrastructure protection market size to grow from USD 102.47 Billion in 2016 to USD 144.82 Billion by 2021, at a Compound Annual Growth Rate (CAGR) of 7.16% from 2016 to 2021. Government regulations & practices and increasing number of cyber threats are the driving factors for the implementation of critical infrastructure protection solutions and technolog …
  • ベンゼンの世界市場予測
    Benzene 2013 World Market Outlook and Forecast is an absolutely essential resource for anyone looking for detailed information on the mentioned market. Using a wide range of primary and secondary sources, we combined, analyzed and presented all available data about benzene market in the all-in-one report issued in a logical and easily accessible format. In addition to the analytical part, the repo …
  • 高度非ホジキンリンパ腫:世界の臨床試験レビュー(2014年上半期)
    High Grade Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “High Grade Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2014" provides data on the High Grade Non-Hodgkin Lymphoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on High Grade Non-Hodgkin Lymphoma. It includes …
  • 世界の白血病治療市場動向(2012-2016)
    TechNavio’s analysts forecast the Global Leukemia Therapeutics market to grow at a CAGR of 10 percent over the period 2012-2016. One of the key factors contributing to this market growth is the significant increase in the number of cancer patients worldwide. The Global Leukemia Therapeutics market has also been witnessing an increase in the number of mergers and acquisitions. However, the delay in …
  • 金属除去液の世界市場2016-2020
    About Removal Fluids Removal fluids are categorized as lubricant or coolants fabricated particularly for metalworking processes, including stamping and machining. There are different sub-segments of removal fluids include oils, oil-water emulsions, air, aerosols (mists), pastes, gels, and gases. Removal fluids may be fabricated with the help of petroleum distillates, plant oils, animal fats, air a …
  • 自動車シフターシャフトの世界市場2015-2019
    About vehicle shifter shaft Shifter shaft is a component of the gearbox that enables synchronization between the driver and the gearbox. They assist the driver in changing gears and maintaining a proper gear ratio. Shifter shafts and gear boxes are very critical components of transmission systems. Technavio's analysts forecast the global commercial vehicle shifter shaft market to grow at a CAGR of …
  • インベストメント鋳造のグローバル市場動向(2014-2018)
    About Investment Casting Investment casting is an industrial process in which high technology waxes are used to form patterns that allow the production of components with accuracy, repeatability, versatility, and integrity in a variety of metals and high-performance alloys. TechNavio's analysts forecast the Global Investment Casting market will grow at a CAGR of 5.68 percent over the period 2014-2 …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。